report-bg

ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market

Analysis by Ad Format (Social Media Ads, Native Ads, Search Engine Ads, Display Ads, Video Advertising, Other Ads); by Platform (Mobile, Desktop, and Other Platforms); and by End User [Pharmaceutical Companies {by Product (Patent Medicine, and Generic Medicine), by Category (Prescription Drugs, and OTC Drugs)}, and Medical Device Companies] – Supply & Demand Analysis & Opportunity Outlook 2022-2035

Buy Now
Report ID: 4702 | Published On: Feb 22, 2023
Request Free Sample Copy
  1. An Outline of the ASEAN and Japan Digital Advertising in Pharma and Medical Equipment Market
    1. Market Definition
    2. Market Segmentation
    3. Product Overview
  2. Assumptions and Abbreviations
  3. Research methodology
    1. Research Process
    2. Primary Research
      1. Manufacturers
      2. Suppliers/Distributers
      3. End Users
    3. Secondary Research
    4. Market Size Estimation
  4. Summary of the Report for Key Decision Makers
  5. Forces of the Market Constituents
    1. Factors/Drivers Impacting the Growth of the Market
    2. Market Trends for Better Business Practices
  6. Key Market Opportunities for Business Growth
  7. Major Roadblocks for the Market Growth
  8. Government Regulations
  9. Technology Transition and Adoption Analysis
  10. Industry Risk Analysis
  11. Global Economic Outlook: Challenges for Recovery and its Impact on ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market
    1. Ukraine-Russia Crisis
    2. Potential US Economic Slowdown
  12. Impact of COVID-19 on ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market
  13. Spending Analysis on Pharma Product Advertising
  14. Industry Supply Chain Analysis
  15. Consumer Behavior Analysis
  16. Analysis on Ongoing Technological Advancement in ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market
  17. End User Analysis
  18. Competitive Positioning: Strategies to Differentiate a Company from its Competitors
  19. Competitive Model: A Detailed Inside View for Investors
    1. Market share analysis, 2022
    2. Business Profiles of Key Enterprises
      1. IQVIA Inc.
      2. Dentsu
      3. Medibrandox
      4. Ogilvy Group
      5. Enthof
      6. Meson Digital Marketing Agency
      7. Indus Net TechShu
      8. MYsense
      9. Indegene
  20. ASEAN Digital Advertising in Pharma and Medical Equipment Market Outlook & Projections, Opportunity Assessment, 2022 to 2035
    1. Market Overview
    2. By Value (USD Million)
      1. By Ad Format
        1. Social Media Ads, Market Value (USD Million), CAGR, 2022-2035F
        2. Native Ads, (USD Million), CAGR, 2022-2035F
        3. Search Engine Ads, (USD Million), CAGR, 2022-2035F
        4. Display Ads, (USD Million), CAGR, 2022-2035F
        5. Video Advertising, (USD Million), CAGR, 2022-2035F
        6. Mobile Advertising, 2022-2035F (USD Million)
        7. Banner Ads, (USD Million), CAGR, 2022-2035F
        8. Other Ads, (USD Million), CAGR, 2022-2035F
      2. By Platform
        1. Mobile, (USD Million), CAGR, 2022-2035F
        2. Desktop, (USD Million), CAGR, 2022-2035F
        3. Other Platforms, (USD Million), CAGR, 2022-2035F
      3. By End User
        1. Pharmaceutical Companies, (USD Million), CAGR, 2022-2035F
        2. By Products, 2022-2033F (USD Million) CAGR, 2022-2035F
          1. Patent Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
          2. Generic Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
        3. Category, 2022-2035F (USD Million), CAGR, 2022-2033F
          1. Prescription Drugs, 2022-2033F (USD Million) CAGR, 2022-2035F
          2. OTC Drugs, 2022-2033F (USD Million), CAGR, 2022-2035F
        4. Medical Device Companies, 2022-2033F (USD Million), CAGR, 2022-2035F
      4. By Geography
        1. Singapore, 2022-2033F (USD Million), CAGR, 2022-2035F
        2. Indonesia, 2022-2033F (USD Million), CAGR, 2022-2035F
        3. Thailand, 2022-2033F (USD Million), CAGR, 2022-2035F
        4. Malaysia, 2022-2033F (USD Million), CAGR, 2022-2035F
        5. Vietnam, 2022-2033F (USD Million), CAGR, 2022-2035F
        6. Philippines, 2022-2033F (USD Million), CAGR, 2022-2035F
        7. Rest of ASEAN, 2022-2033F (USD Million), CAGR, 2022-2035F
  21. Singapore Digital Advertising in Pharma and Medical Equipment Market Outlook & Projections, Opportunity Assessment, 2022 to 2035
    1. Market Overview
    2. By Value (USD million)
      1. By Ad Format
        1. Social Media Ads, Market Value (USD Million), CAGR, 2022-2035F
        2. Native Ads, (USD Million), CAGR, 2022-2035F
        3. Search Engine Ads, (USD Million), CAGR, 2022-2035F
        4. Display Ads, (USD Million), CAGR, 2022-2035F
        5. Video Advertising, (USD Million), CAGR, 2022-2035F
        6. Mobile Advertising, 2022-2035F (USD Million)
        7. Banner Ads, (USD Million), CAGR, 2022-2035F
        8. Other Ads, (USD Million), CAGR, 2022-2035F
      2. By Platform
        1. Mobile, (USD Million), CAGR, 2022-2035F
        2. Desktop, (USD Million), CAGR, 2022-2035F
        3. Other Platforms, (USD Million), CAGR, 2022-2035F
      3. By End User
        1. Pharmaceutical Companies, (USD Million), CAGR, 2022-2035F
        2. By Products, 2022-2033F (USD Million) CAGR, 2022-2035F
          1. Patent Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
          2. Generic Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
        3. Category, 2022-2035F (USD Million), CAGR, 2022-2033F
          1. Prescription Drugs, 2022-2033F (USD Million) CAGR, 2022-2035F
          2. OTC Drugs, 2022-2033F (USD Million), CAGR, 2022-2035F
        4. Medical Device Companies, 2022-2033F (USD Million), CAGR, 2022-2035F
  22. Indonesia Digital Advertising in Pharma and Medical Equipment Market Outlook & Projections, Opportunity Assessment, 2022 to 2035
    1. Market Overview
    2. By Value (USD Million)
      1. By Ad Format
        1. Social Media Ads, Market Value (USD Million), CAGR, 2022-2035F
        2. Native Ads, (USD Million), CAGR, 2022-2035F
        3. Search Engine Ads, (USD Million), CAGR, 2022-2035F
        4. Display Ads, (USD Million), CAGR, 2022-2035F
        5. Video Advertising, (USD Million), CAGR, 2022-2035F
        6. Mobile Advertising, 2022-2035F (USD Million)
        7. Banner Ads, (USD Million), CAGR, 2022-2035F
        8. Other Ads, (USD Million), CAGR, 2022-2035F
      2. By Platform
        1. Mobile, (USD Million), CAGR, 2022-2035F
        2. Desktop, (USD Million), CAGR, 2022-2035F
        3. Other Platforms, (USD Million), CAGR, 2022-2035F
      3. By End User
        1. Pharmaceutical Companies, (USD Million), CAGR, 2022-2035F
        2. By Products, 2022-2033F (USD Million) CAGR, 2022-2035F
          1. Patent Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
          2. Generic Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
        3. Category, 2022-2035F (USD Million), CAGR, 2022-2033F
          1. Prescription Drugs, 2022-2033F (USD Million) CAGR, 2022-2035F
          2. OTC Drugs, 2022-2033F (USD Million), CAGR, 2022-2035F
        4. Medical Device Companies, 2022-2033F (USD Million), CAGR, 2022-2035F
  23. Thailand Digital Advertising in Pharma and Medical Equipment Market Outlook & Projections, Opportunity Assessment, 2022 to 2035
    1. Market Overview
    2. By Value (USD Million)
      1. By Ad Format
        1. Social Media Ads, Market Value (USD Million), CAGR, 2022-2035F
        2. Native Ads, (USD Million), CAGR, 2022-2035F
        3. Search Engine Ads, (USD Million), CAGR, 2022-2035F
        4. Display Ads, (USD Million), CAGR, 2022-2035F
        5. Video Advertising, (USD Million), CAGR, 2022-2035F
        6. Mobile Advertising, 2022-2035F (USD Million)
        7. Banner Ads, (USD Million), CAGR, 2022-2035F
        8. Other Ads, (USD Million), CAGR, 2022-2035F
      2. By Platform
        1. Mobile, (USD Million), CAGR, 2022-2035F
        2. Desktop, (USD Million), CAGR, 2022-2035F
        3. Other Platforms, (USD Million), CAGR, 2022-2035F
      3. By End User
        1. Pharmaceutical Companies, (USD Million), CAGR, 2022-2035F
        2. By Products, 2022-2033F (USD Million) CAGR, 2022-2035F
          1. Patent Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
          2. Generic Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
        3. Category, 2022-2035F (USD Million), CAGR, 2022-2033F
          1. Prescription Drugs, 2022-2033F (USD Million) CAGR, 2022-2035F
          2. OTC Drugs, 2022-2033F (USD Million), CAGR, 2022-2035F
        4. Medical Device Companies, 2022-2033F (USD Million), CAGR, 2022-2035F
  24. Malaysia Digital Advertising in Pharma and Medical Equipment Market Outlook & Projections, Opportunity Assessment, 2022 to 2035
    1. Market Overview
    2. By Value (USD Million)
      1. By Ad Format
        1. Social Media Ads, Market Value (USD Million), CAGR, 2022-2035F
        2. Native Ads, (USD Million), CAGR, 2022-2035F
        3. Search Engine Ads, (USD Million), CAGR, 2022-2035F
        4. Display Ads, (USD Million), CAGR, 2022-2035F
        5. Video Advertising, (USD Million), CAGR, 2022-2035F
        6. Mobile Advertising, 2022-2035F (USD Million)
        7. Banner Ads, (USD Million), CAGR, 2022-2035F
        8. Other Ads, (USD Million), CAGR, 2022-2035F
      2. By Platform
        1. Mobile, (USD Million), CAGR, 2022-2035F
        2. Desktop, (USD Million), CAGR, 2022-2035F
        3. Other Platforms, (USD Million), CAGR, 2022-2035F
      3. By End User
        1. Pharmaceutical Companies, (USD Million), CAGR, 2022-2035F
        2. By Products, 2022-2033F (USD Million) CAGR, 2022-2035F
          1. Patent Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
          2. Generic Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
        3. Category, 2022-2035F (USD Million), CAGR, 2022-2033F
          1. Prescription Drugs, 2022-2033F (USD Million) CAGR, 2022-2035F
          2. OTC Drugs, 2022-2033F (USD Million), CAGR, 2022-2035F
        4. Medical Device Companies, 2022-2033F (USD Million), CAGR, 2022-2035F
  25. Vietnam Digital Advertising in Pharma and Medical Equipment Market Outlook & Projections, Opportunity Assessment, 2022 to 2035
    1. Market Overview
    2. By Value (USD Million)
      1. By Ad Format
        1. Social Media Ads, Market Value (USD Million), CAGR, 2022-2035F
        2. Native Ads, (USD Million), CAGR, 2022-2035F
        3. Search Engine Ads, (USD Million), CAGR, 2022-2035F
        4. Display Ads, (USD Million), CAGR, 2022-2035F
        5. Video Advertising, (USD Million), CAGR, 2022-2035F
        6. Mobile Advertising, 2022-2035F (USD Million)
        7. Banner Ads, (USD Million), CAGR, 2022-2035F
        8. Other Ads, (USD Million), CAGR, 2022-2035F
      2. By Platform
        1. Mobile, (USD Million), CAGR, 2022-2035F
        2. Desktop, (USD Million), CAGR, 2022-2035F
        3. Other Platforms, (USD Million), CAGR, 2022-2035F
      3. By End User
        1. Pharmaceutical Companies, (USD Million), CAGR, 2022-2035F
        2. By Products, 2022-2033F (USD Million) CAGR, 2022-2035F
          1. Patent Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
          2. Generic Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
        3. Category, 2022-2035F (USD Million), CAGR, 2022-2033F
          1. Prescription Drugs, 2022-2033F (USD Million) CAGR, 2022-2035F
          2. OTC Drugs, 2022-2033F (USD Million), CAGR, 2022-2035F
        4. Medical Device Companies, 2022-2033F (USD Million), CAGR, 2022-2035F
  26. Philippines Digital Advertising in Pharma and Medical Equipment Market Outlook & Projections, Opportunity Assessment, 2022 to 2035
    1. Market Overview
    2. By Value (USD Million)
      1. By Ad Format
        1. Social Media Ads, Market Value (USD Million), CAGR, 2022-2035F
        2. Native Ads, (USD Million), CAGR, 2022-2035F
        3. Search Engine Ads, (USD Million), CAGR, 2022-2035F
        4. Display Ads, (USD Million), CAGR, 2022-2035F
        5. Video Advertising, (USD Million), CAGR, 2022-2035F
        6. Mobile Advertising, 2022-2035F (USD Million)
        7. Banner Ads, (USD Million), CAGR, 2022-2035F
        8. Other Ads, (USD Million), CAGR, 2022-2035F
      2. By Platform
        1. Mobile, (USD Million), CAGR, 2022-2035F
        2. Desktop, (USD Million), CAGR, 2022-2035F
        3. Other Platforms, (USD Million), CAGR, 2022-2035F
      3. By End User
        1. Pharmaceutical Companies, (USD Million), CAGR, 2022-2035F
        2. By Products, 2022-2033F (USD Million) CAGR, 2022-2035F
          1. Patent Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
          2. Generic Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
        3. Category, 2022-2035F (USD Million), CAGR, 2022-2033F
          1. Prescription Drugs, 2022-2033F (USD Million) CAGR, 2022-2035F
          2. OTC Drugs, 2022-2033F (USD Million), CAGR, 2022-2035F
        4. Medical Device Companies, 2022-2033F (USD Million), CAGR, 2022-2035F
  27. Rest of ASEAN Digital Advertising in Pharma and Medical Equipment Market Outlook & Projections, Opportunity Assessment, 2022 to 2035
    1. Market Overview
    2. By Value (USD Million)
      1. By Ad Format
        1. Social Media Ads, Market Value (USD Million), CAGR, 2022-2035F
        2. Native Ads, (USD Million), CAGR, 2022-2035F
        3. Search Engine Ads, (USD Million), CAGR, 2022-2035F
        4. Display Ads, (USD Million), CAGR, 2022-2035F
        5. Video Advertising, (USD Million), CAGR, 2022-2035F
        6. Mobile Advertising, 2022-2035F (USD Million)
        7. Banner Ads, (USD Million), CAGR, 2022-2035F
        8. Other Ads, (USD Million), CAGR, 2022-2035F
      2. By Platform
        1. Mobile, (USD Million), CAGR, 2022-2035F
        2. Desktop, (USD Million), CAGR, 2022-2035F
        3. Other Platforms, (USD Million), CAGR, 2022-2035F
      3. By End User
        1. Pharmaceutical Companies, (USD Million), CAGR, 2022-2035F
        2. By Products, 2022-2033F (USD Million) CAGR, 2022-2035F
          1. Patent Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
          2. Generic Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
        3. Category, 2022-2035F (USD Million), CAGR, 2022-2033F
          1. Prescription Drugs, 2022-2033F (USD Million) CAGR, 2022-2035F
          2. OTC Drugs, 2022-2033F (USD Million), CAGR, 2022-2035F
        4. Medical Device Companies, 2022-2033F (USD Million), CAGR, 2022-2035F
  28. Japan Digital Advertising in Pharma and Medical Equipment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. By Value (USD Million)
      1. By Ad Format
        1. Social Media Ads, Market Value (USD Million), CAGR, 2022-2035F
        2. Native Ads, (USD Million), CAGR, 2022-2035F
        3. Search Engine Ads, (USD Million), CAGR, 2022-2035F
        4. Display Ads, (USD Million), CAGR, 2022-2035F
        5. Video Advertising, (USD Million), CAGR, 2022-2035F
        6. Mobile Advertising, 2022-2035F (USD Million)
        7. Banner Ads, (USD Million), CAGR, 2022-2035F
        8. Other Ads, (USD Million), CAGR, 2022-2035F
      2. By Platform
        1. Mobile, (USD Million), CAGR, 2022-2035F
        2. Desktop, (USD Million), CAGR, 2022-2035F
        3. Other Platforms, (USD Million), CAGR, 2022-2035F
      3. By End User
        1. Pharmaceutical Companies, (USD Million), CAGR, 2022-2035F
        2. By Products, 2022-2033F (USD Million) CAGR, 2022-2035F
          1. Patent Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
          2. Generic Medicine, 2022-2033F (USD Million), CAGR, 2022-2035F
        3. Category, 2022-2035F (USD Million), CAGR, 2022-2033F
          1. Prescription Drugs, 2022-2033F (USD Million) CAGR, 2022-2035F
          2. OTC Drugs, 2022-2033F (USD Million), CAGR, 2022-2035F
        4. Medical Device Companies, 2022-2033F (USD Million), CAGR, 2022-2035F

ASEAN and Japan Digital Advertising in Pharma and Medical Equipment Market Size, Forecast, and Trend Highlights Over 2022-2035

The ASEAN & Japan digital advertising in pharma and medical equipment market is estimated to garner a revenue of USD 1,574.6 Million and USD 4,625.2 Million respectively by the end of 2035 by growing at a CAGR of 10.85% and 10.68% respectively over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of USD 508.9 Million and USD 1,520.9 Million respectively in the year 2022. The growth of the market can be attributed to growing penetration of internet in ASEAN region or Japan, further boosting the growth in social media users. Over 399 million people utilize the internet, and Southeast Asia is a thriving emerging market with a thriving digital economy. Further, more than 1 billion social media users, primarily in China, were based in Eastern Asia in 2022. In addition, about 840 million people in Southern Asia used social media.  With more people using the internet, pharmaceutical and medical equipment companies would have a huge advantage in spreading their products and information through digital marketing platforms including social media ads, video commercials, mobile ads, and others.

ASEAN-and-Japan-Digital-Advertising-in-Pharma-and-Medical-Equipment-Market-scope.jpg

In the pharmaceutical and medical equipment industries, digital advertising strives to persuade the intended consumer to learn more about their products, including making a purchase, and it aids in boosting website traffic and brand recognition. Further, there has also been growing use of email marketing in pharmaceutical industries. One of the key routes for establishing and expanding communication between pharmaceutical companies, patients, and HCPs is email. As a marketing tool, email enables company to send recipients well-targeted communications, emphasizing the main content of the emails, and it is a quick and easy way to get in touch with the target market. However, many marketing specialists working in the pharma domain presently confront several difficulties when it comes to a deeper understanding of the influence of email communication. Hence, the demand for various powerful email approach such as interactive email is estimated to increase.


ASEAN-and-Japan-Digital-Advertising-in-Pharma-and-Medical-Equipment-Market-scope.jpg
Get more information on this report: Request Sample PDF

ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

ASEAN Market CAGR

10.85%

Japan Market CAGR

10.68%

 ASEAN Base Year Market Size (2022)

USD 508.9 Million

Japan Base Year Market Size (2022) 

USD 1,520.9 Million

ASEAN Forecast Year Market Size (2035)

USD 1,574.6 Million

Japan Forecast Year Market Size (2035)

USD 4,625.2 Million

Regional Scope

  • ASEAN (Singapore, Indonesia, Thailand, Malaysia, Vietnam, Philippines, and Rest of ASEAN)
  • Japan


ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market: Growth Drivers and Challenges

Growth Drivers

  • Growing Penetration of Mobile Phones- Southeast Asia were expected to have about 320 million smartphone users by 2022, and that figure would continue to grow until 2026. Any type of advertising that appears on devices either of those as smartphones and tablet computers is referred to as mobile advertising. Companies could use SMS text ads or banner ads that are placed on mobile websites to advertise on these devices. Additionally, company could also advertise their product on social media. Hence, owing to the large number of people using smartphones, it has become easy for pharma and medical equipment company to advertise their products.

  • Surge in Social Media User - India has about 447 million active social media users, or around 30% of the country's total population. Approximately 98% of these (about 444 million) use their mobile phones to access social media.

  • Growth in Pharma and Medical Equipment Company - In an effort to lure Japanese pharmaceutical and medical device manufacturers to India, the Indian government has urged them to establish businesses in Gujarat, Telangana, Andhra Pradesh, Himachal Pradesh, and Goa. According to estimates, Japanese businesses would invest about 26 Million in this industry.

  • Upsurge of Users on Email - About 3 billion people use email every day. As a result, the vast majority of email marketers incorporate mobile-friendly communications into their marketing plans.

  • Growth in Internet User - In Japan, there were around 114 million internet users in 2021. This figure was anticipated to climb to roughly 115 million internet users by 2026.

Challenges

  • Growing Competition in the Digital Advertising Market - The development of digital advertising in the market for pharmaceuticals and medical equipment is anticipated to be constrained by increased competition. A record number of companies have entered the digital market, and as a result, demand has surged and brand costs have gone up. In light of the increased competition, marketers must be more strategic and intelligent to stand out in the digital age. Hence, creating engaging content has become necessary. However, consumers have evolved noise-cancelling abilities as a result of the constant barrage of digital marketing content. Hence, this factor is estimated to hinder the market growth.
  • Complexity in Operation
  • Lack of Professional in Order to Create Engaging Content


ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market Segmentation

The ASEAN & Japan digital advertising in pharma and medical equipment market is segmented and analyzed for demand and supply by platform into mobile, desktop, and other platforms. Out of these, the mobile segment is anticipated to hold the largest market revenue of USD 1,298.6 Million and USD 3,404.1 Million respectively by the end of 2035, up from a revenue of USD 402.7 Million and USD 1,070.7 Million in the year 2022. Further, the segment is anticipated to grow at a highest CAGR of 11.27% and 11.13% respectively. The growth of the segment can be attributed to growing penetration of mobile phones. In Japan, there were more than 100 million smartphone users in 2022. By 2027, it was anticipated to surpass about 114 million, an increase of around 27 million users from 2018. The most successful online kind of advertising is mobile advertising. Large number of people are estimate to use mobile daily and every time no matter what they are doing. Hence, pharma and medical equipment finds it more convenient to advertise on mobile phones.

The ASEAN & Japan digital advertising in pharma and medical equipment market is also segmented and analyzed for demand and supply by ad format into social media ads, native ads, search engine ads, display ads, video advertising, mobile advertising, banner ads, and others ads. Amongst these, the search engine ads segment is estimated to generate the highest revenue of USD 467.1 Million and 1,375.1 Million respectively by the end of 2035, up from a revenue of USD 164.8 Million and 494.3 Million respectively in the year 2022. Advertising that appears on search engines including Google, Yahoo, and Bing on mobile devices, tablets, desktop computers, and linked TVs is referred to as search engine advertising. Being prominently displayed on search engine results pages increases the visibility of brands and products, and this has been proven to be a successful strategy for pharma and medical equipment firms over the past decade. However, the video advertising segment is estimated to grow at a highest CAGR 12.40% and 12.12% respectively over the forecast period. Videos are estimated to be more engaging than any other channel. Hence, more company are expected to use video advertising in order to promote their products over the forecast period.

Our in-depth analysis of the ASEAN & Japan digital advertising in pharma and medical equipment market includes the following segments:

                        By Ad Format

  • Social Media Ads
  • Native Ads
  • Search Engine Ads
  • Display Ads
  • Video Advertising
  • Mobile Advertising
  • Banner Ads
  • Other Ads

                    By Platform

  • Mobile
  • Desktop
  • Other Platforms

                   By End User

  • Pharmaceutical Companies
    • By Product
      • Patent Medicine
      • Generic Medicine
    • By Category
      • Prescription Drugs
      • OTC Drugs
  • Medical Device Companies

 


ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market Regional Synopsis

The Indonesia digital advertising in pharma and medical equipment market, amongst the market in all the other regions, is projected to hold the largest market revenue of USD 906.3 Million by the end of 2035, up from a revenue of USD 277.0 Million in the year 2022. Further, the market in this country is estimated to grow at a highest CAGR of 11.41% over the forecast period, backed by increase in the number of internet users over time, as well as surge in number of mobile and social media users. Indonesia had over about 190 million active social media users as of February 2022, placing third in the Asia Pacific after China and India.

Additionally, the market in Philippines is estimated to generate the second highest revenue of USD 207.7 Million by the end of 2035, up from a revenue of USD 74.0 Million in the year 2022. The growth of the market in this region can be attributed to growing focus on digital transformation of businesses along with surging strategies for social media and digital advertising. Philippines is recognized as one of the top countries for internet users worldwide regarding time spent on social media. Hence this factor is also estimated to boost the growth of the market in this region.

Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the ASEAN & Japan Digital Advertising in Pharma and Medical Equipment Market

    Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the AEAN & Japan digital advertising in pharma and medical equipment market that are included in our report are, IQVIA Inc., Dentsu, Medibrandox, Ogilvy Group, Enthof, Meson Digital Marketing Agency, Indus Net TechShu, Indegene, Mysense, and others.  


In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the ASEAN & Japan digital advertising market?

Ans: The major factors driving the growth of the growth of the market are growing penetration of mobile phones, surge in social media users, growth in pharma and medical equipment company, and others.

2) What would be the CAGR of ASEAN & Japan digital advertising market over the forecast period?

Ans: The market is anticipated to attain a CAGR of 10.85% and 10.68% respectively over the forecast period, i.e., 2023 – 2035.

3) What are the challenges affecting the ASEAN & Japan digital advertising market growth?

Ans: Growing competition in the digital advertising, complexity in operation, and lack of professional in order to create engaging content are estimated to be the growth hindering factors for the market expansion.

5) Who are the major players dominating the ASEAN & Japan digital advertising market?

Ans: The major players in the market are IQVIA Inc., Dentsu, Medibrandox, Ogilvy Group, and more.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the ASEAN & Japan digital advertising in pharma and medical equipment market?

Ans: The market is segmented by ad format, platform, end user, and by region.

8) Which segment captures the largest market size in the platform segment in the ASEAN & Japan

Ans: The mobile segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample